american society of anesthesiologists glp-1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Glucagon-Like Peptide-1 Receptor Agonists–Health Professional

This study shows why a molecule with a protective endogenous role can have an undesirable effect when delivered through a different route or formulation

Consulting a dermatologist or medical professional is strongly recommended

Abdolrasulnia and Wood 1980)

While these purported effects may spike the interest of peptide researchers, it should be stressed that melanotan 2 is a research chemical and has no safe dosage in human test subjects

By attaching to GLP-1 receptors in the pancreas, it triggers a rise in the glucose-dependent release of insulin from beta cells, inhibiting glucagon secretion, slowing down the emptying of the stomach, and decreasing food consumption